BridgeMD
New treatment option for ST+ABR
Official title Shaping Habitual Impulses For a Tobacco-free Style
ClinicalTrials.gov ID: NCT07025772
What this study is testing
- What it's testing
- The present investigation aims to assess the efficacy of an innovative and novel smoking cessation intervention that integrates approach bias retraining (ABR) and standard smoking cessation treatment (ST). Participants will be randomized to either: (1) standard smoking cessation treatment and approach bias retraining (ST+ABR); (2) ST+Sham; or (3) ST-only.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least 18 years of age
- Ability to speak English fluently
- Ability to read English fluently
- Ability to write in English fluently
- Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement
You likely can't join if
- Having used an e-cigarette in the past 3 months
- Having initiated any mental health therapy or pharmacotherapy within the past 3 months
- Being currently in therapy for substance abuse (including nicotine dependence)
- Being currently enrolled in any other studies at the RESTORE lab to help quit smoking
- Currently using any NRT or psychotherapy products for nicotine cessation
- Currently using Bupropion as a smoking cessation aid and antidepressant
See the full eligibility criteria
- At least 18 years of age
- Ability to speak English fluently
- Ability to read English fluently
- Ability to write in English fluently
- Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement
- Motivated to quit smoking
- Willing to attend in-person visits
- Provide written informed consent, accepting study and the assigned by chance group assignment
- English literacy of 7th grade or higher, as indicated by a score of 4 or greater on the Rapid Estimate of Adult Literacy in Medicine-Short Form (REALM-SF)
- Having used an e-cigarette in the past 3 months
- Having initiated any mental health therapy or pharmacotherapy within the past 3 months
- Being currently in therapy for substance abuse (including nicotine dependence)
- Being currently enrolled in any other studies at the RESTORE lab to help quit smoking
- Currently using any NRT or psychotherapy products for nicotine cessation
- Currently using Bupropion as a smoking cessation aid and antidepressant
- Currently pregnant or planning to become pregnant
- Having high blood pressure that is not under control
- Having a heart attack within the past 2 weeks
- Having Visual impairments
- Hand-motoric impairments
- Currently suicidal or high suicide risk or current or past psychotic disorders of any type, bipolar disorder, schizophrenia or schizoaffective disorder, anorexia, bulimia assessed using the Mini Neuropsychiatric...
- Cognitive impairment, verified via a score of ≥8 on the Six-Item Cognitive Impairment Test (6-CIT)
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.